PEPTIDES for Veterans Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Latest action
- Sep 8
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What it does
The PEPTIDES for Veterans Act would direct the Secretary of Veterans Affairs to review and define peptide-based therapies, study their safety and potential benefits for veterans with service-connected conditions, and, if warranted, implement a pilot program to evaluate their use in VA medical facilities. The bill requires the Secretary to submit reports to Congress within 180 days of enactment (on regulations and definitions), complete a study within 18 months after that report, and, if appropriate, launch a voluntary pilot program lasting up to five years to assess real-world effectiveness. The legislation aims to expand access to innovative treatments for veterans by building an evidence-based foundation for peptide-based therapies within the VA healthcare system.
AI summary · The lawmakers haven’t published an official summary of this bill yet, so 52 wrote this one from the bill’s text.
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Work with this bill
Where it goes next
While a bill can still move, the questions are about people and money.
- Who sits in the seats that vote on itA roster is not a certified tally, and a filing is not a place on the ballot.
- Who funds the people decidingA receipt is not backing. A contribution does not establish a policy motive.
- Who is paid to be heardNaming an institution is the filer's account, not a record of any meeting.
- Bills still moving in CongressNewest first, the ones that can still change